EBQ:ProMISe Trial: Difference between revisions
Neil.m.young (talk | contribs) No edit summary |
Neil.m.young (talk | contribs) No edit summary |
||
Line 45: | Line 45: | ||
*CD4 count <50 | *CD4 count <50 | ||
*Advance directive that restricts either protocol | *Advance directive that restricts either protocol | ||
Contraindication to interventions including refusal of blood transfusions | *Contraindication to interventions including refusal of blood transfusions | ||
*Pregnant | *Pregnant | ||
*Transfer patient | *Transfer patient |
Revision as of 04:47, 7 May 2015
incomplete Journal Club Article
Mouncey PR, Osborn TM, Power GS, et al. "Trial of Early, Goal-Directed Resuscitation for Septic Shock". NEJM. 2015. 14(372):1301-1311.
PubMed Full text
PubMed Full text
Clinical Question
Is there a different between EGDT versus “usual care” in 90-day mortality?
Conclusion
Using EGDT did not lead to an improved outcome
Major Points
Study Design
Population
56 hospitals in the UK
Patient Demographics
Inclusion Criteria
- ≥18 years of age
- Within 6 hours of presenting to ED
- Known or presumed infection
- 2 or more SIRS criteria
- Refractory hypotension (<90 SBP or <65 MAP after 1L IVF trial) or hyperlactatemia (≥4.0)
Exclusion Criteria
- CVA
- ACS
- Cardiac dysrhythmia
- Acute pulmonary edema
- GI bleed
- Seizure
- Drug overdose
- Burn or trauma
- Immediate surgery needed
- CD4 count <50
- Advance directive that restricts either protocol
- Contraindication to interventions including refusal of blood transfusions
- Pregnant
- Transfer patient